Under terms of both agreements, the Clients’ sales representatives will use AxcelRx Live to provide live education of their participating specialty brands to key targeted physicians in the U.S. Specialty physicians will also be targeted with AxcelRx Virtual, a suite of supplemental educational services available to the physician 24/7, such as self-directed online presentations. Aptilon links physicians to bio-pharma-sponsored programs through its ReachNetSM physician access channel, an extensive network of partner and company-owned websites, with access to more than 450,000 opted-in physicians.
“We spent the past year building relationships with key pharmaceuticals companies and educating the marketplace about our unique live and internet-based marketing and sales solution. We now see AxcelRx Live gaining momentum and 2008 is rapidly becoming a significant year for Aptilon, as our strategy is proving to be successful,” said Denis Martineau, President of Aptilon. “These new agreements demonstrate that pharmaceutical brand marketers are increasingly recognizing the value of our alternative sales and marketing channel. We look forward to providing our new clients with our unique services to interact with hard-to-reach specialty physicians and deliver their brands’ educational messages.”
About Aptilon
Aptilon enables pharmaceutical, biotech and medical device companies to effectively reach and interact with physicians via the Internet through its innovative AxcelRx Live video detailing (with company reps), virtual programs, peer selling and other sales and marketing programs. Leading health care companies have adopted Aptilon’s ReachNet physician access channel, driving tens of thousands of high-quality rep-physician interactions averaging eight to 10 minutes in length for primary care physicians and up to 15 minutes for specialists. Aptilon provides the infrastructure necessary for sales representatives to build physician awareness, understanding and preference during all stages of a product’s life cycle, from pre-launch education through end stage support. For more information, visit www.aptilon.com.
AxcelRxSM and ReachNetSM are service marks of Aptilon Corporation.
Forward-looking statements
This news release contains forward-looking information. These statements relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management of Aptilon. A number of factors could cause actual events, performance or results to differ materially from the events performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and Aptilon does not assume any obligation to update or revise them to reflect new events or circumstances.
###
The TSX Venture Exchange Inc. has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
